Intelligence Feed event · Equity · 2026-09-26

    Staar Surgical Board Authorizes $50M Share Repurchase Program

    Question

    Staar Surgical Board Authorizes $50M Share Repurchase Program

    Direct answer

    Staar Surgical's board approved an authorization permitting up to $50 million in equity buybacks. Management cited internal balance sheet health and current market mispricing relative to cash-generation capability. The stock responded with an immediate 7.5% advance. The buyback provides downside price support, though real EPS accretion will depend on the cadence of open-market repurchases over the next two quarters.

    Original publisher
    Market Ontology
    Evidence through
    2026-09-26
    Published
    2026-10-20
    Revision
    1 · 2026-10-20

    Cite as: Market Ontology, “Staar Surgical Board Authorizes $50M Share Repurchase Program”, revision 1, evidence through 2026-09-26. https://marketontology.com/market-events/2026-09-26/staar-surgical-board-authorizes-50m-share-repurchase-program-0d3511

    EQUITY
    Staar Surgical Board Authorizes $50M Share Repurchase Program
    Staar Surgical's board approved an authorization permitting up to $50 million in equity buybacks. Management cited internal balance sheet health and current market mispricing relative to cash-generation capability. The stock responded with an immediate 7.5% advance. The buyback provides downside price support, though real EPS accretion will depend on the cadence of open-market repurchases over the next two quarters.
    STAA
    Impact
    67
    SEP 26
    SIG
    88%
    STAA
    Staar Surgical Board Authorizes $50M Share Repurchase Program
    Staar Surgical's board approved an authorization permitting up to $50 million in equity buybacks. Management cited internal balance sheet health and current market mispricing relative to cash-generation capability. The stock responded with an immediate 7.5% advance. The buyback provides downside price support, though real EPS accretion will depend on the cadence of open-market repurchases over the next two quarters.
    → Direct share repurchases of $50 million reduce STAA diluted share count and support EPS figures across upcoming reporting quarters.
    Impact
    Staar Surgical's board approved an authorization permitting up to $50 million in equity buybacks. Management cited internal balance sheet health and current market mispricing relative to cash-generation capability. The stock responded with an immediate 7.5% advance. The buyback provides downside price support, though real EPS accretion will depend on the cadence of open-market repurchases over the next two quarters.
    Affected
    STAA
    Transmission
    Direct share repurchases of $50 million reduce STAA diluted share count and support EPS figures across upcoming reporting quarters.

    How this development reaches the affected companies

    AssetExposure and channelDirectionEvidence
    STAAequity supply reduction via open-market buyback executionUp1-4wStaar Surgical board authorized $50M repurchase program after 7.5% single-session gain.

    Does this development affect your holdings?

    Enter your holdings to check them against this and other recent developments, review the decision that matters most, then set a monitor.

    Check this development against my holdings

    Review your initial audit before choosing ongoing portfolio scanning at $79/month.

    What happened next

    AssetCallBase close+1 day+5 days+20 days
    STAAUpagreed20.51 2026-09-25+1.76%+9.56%Pending

    Closing prices from stored daily bars; returns measured from the last close on or before the event date. Not a recommendation.

    No verifiable public source recorded for this card.

    Related

    Check this development against my holdings

    See today's live cards

    Public pages are published 24 hours after the product shows them. Desk shows every catalyst, event and causal reading as it happens, mapped to your holdings.

    Open Desk — $399/month